CurvaFix, Inc. is a Bellevue, Washington medical device company that developed the CurvaFix IM Implant - the first new intramedullary technology for pelvic trauma in three decades. Its curved, steerable rodscrew follows the natural shape of the pelvis, enabling strong internal fixation through a single small incision. The device is designed to reduce pain, support early weight-bearing, and speed recovery for patients with high- and low-energy pelvic fractures, including the growing population of elderly patients with fragility fractures of the pelvis.
Mark Foster is the president and CEO of CurvaFix, a Bellevue, Washington medical device company building curved intramedullary implants that follow the natural bend of the pelvis to repair fractures. He took the top job in July 2023, the same week the company closed a $39 million Series C led by MVM Partners, and his mandate is commercial scale: turning a novel, FDA-cleared implant into a nationally distributed product. Before CurvaFix he ran Trice Medical and led the U.S. sports medicine business at Smith & Nephew, part of roughly 24 years spent almost entirely inside orthopedics and medical devices.